The In Vitro and In Vivo Anticancer Properties of Chalcone Flavokawain B through Induction of ROS-Mediated Apoptotic and Autophagic Cell Death in Human Melanoma Cells

You-Cheng Hseu,Yu-Chi Chiang,Yugandhar Vudhya Gowrisankar,Kai-Yuan Lin,Sheng-Teng Huang,Sirjana Shrestha,Geng-Ruei Chang,Hsin-Ling Yang

DOI: https://doi.org/10.3390/cancers12102936

2020-10-12

Cancers

Abstract:Melanoma is the most prevalent type of skin cancer with high mortality rates. This study demonstrates the in vitro and in vivo anticancer properties of chalcone flavokawain B (FKB) induced ROS-mediated apoptosis and autophagy in human melanoma (human epithelial melanoma cell line A375 and/or human skin lymph node derived melanoma cell line A2058) cells. Cell viability was calculated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and the expression patterns of various apoptosis, autophagy-associated proteins were determined by Western blot methods. Annexin V was detected by flow cytometry, whereas acidic vesicular organelles (AVOs) and intracellular ROS levels were measured by fluorescence microscopy. The in vivo anticancer properties of FKB were evaluated by xenografting the A375 cells into nude mice. The results convey that FKB inhibited cell viability, B-Raf proto-oncogene, serine/threonine kinase (BRAF)/extracellular signal-regulated kinase (ERK) expression in human melanoma cells. Caspase-3 activation, poly (ADP-ribose) polymerase (PARP) cleavage pathway, and Bcl2 associated X (Bax)/B-cell lymphoma 2 (Bcl-2) dysregulation were involved in the execution of apoptosis. Moreover, FKB-induced autophagy was observed through increased microtubule-associated protein 1A/1B-light chain 3B (LC3-II) accumulation and AVOs formation, which was also associated with an increase in sequestosome 1 (SQSTM1/p62), decreased protein kinase B (AKT)/mammalian target of rapamycin (mTOR) expressions, and dysregulated Beclin-1/Bcl-2 levels. Autophagy inhibitors [3-methyladenine (3-MA)/chloroquine (CQ)] and LC3 silencing suppressed FKB-induced apoptosis by decreasing caspase-3 in melanoma cells. The antioxidant N-acetylcysteine (NAC) diminished FKB-induced apoptotic and autophagic cell death. However, the inhibition of apoptosis decreased FKB-induced autophagy (LC3-I/II). The in vivo study confirmed that FKB inhibited melanoma growth in A375-xenografted nude mice. This study concluded that FKB is critically associated with the execution and generation of ROS-modulated apoptotic and autophagic cell death of melanoma cells. FKB also repressed tumor growth in xenografted nude mice. Therefore, flavokawain B might be a potential anti-tumor agent in human melanoma treatment.

oncology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the anti - tumor effect and its mechanism of the natural compound Flavokawain B (FKB) on human melanoma cells (specifically, human epithelial melanoma cell line A375 and/or human skin - lymph - node - derived melanoma cell line A2058). Specifically, the study aims to explore whether FKB can inhibit the growth and survival of melanoma cells through reactive oxygen species (ROS) - mediated apoptosis and autophagy by in vitro and in vivo experimental methods. The paper mentions that melanoma is one of the most deadly skin cancers. Its incidence rate is increasing year by year, and ultraviolet exposure is the main environmental risk factor. Although significant progress has been made in the detection and treatment of melanoma, its prognosis is still not satisfactory. Therefore, it is of great significance to find effective treatment methods. FKB is a naturally occurring chalcone and is known to have antiproliferative pharmacological activities against a variety of cancer cells, but its anti - tumor effect on melanoma cells has not been studied yet. The research results of this paper support the potential application prospect of FKB in the treatment of human melanoma cancer. The research results show that FKB can significantly reduce the viability of A375 and A2058 cells, and this effect is dose - dependent. In addition, FKB can also activate caspase - 3, promote PARP cleavage, and up - regulate the expression of the pro - apoptotic protein Bax while down - regulating the expression of the anti - apoptotic protein Bcl - 2, thereby inducing the apoptosis of melanoma cells. In addition, FKB also activates the autophagy process by increasing the accumulation of LC3 - II and the formation of acidic vesicular organelles (AVOs), which is related to the inhibition of the mTOR signaling pathway. These findings suggest that FKB may effectively inhibit the growth of melanoma cells through ROS - mediated apoptosis and autophagy pathways, indicating its potential as an anticancer drug.

The In Vitro and In Vivo Anticancer Properties of Chalcone Flavokawain B through Induction of ROS-Mediated Apoptotic and Autophagic Cell Death in Human Melanoma Cells

Antiproliferative Evaluation in Vitro of a New Chalcone Inducing Apoptosis by ROS Generation Against MGC-803 Cells

Chalcone flavokawain B induces autophagic-cell death via reactive oxygen species-mediated signaling pathways in human gastric carcinoma and suppresses tumor growth in nude mice

Anticancer activities of chalcone flavokawain B from Alpinia pricei Hayata in human lung adenocarcinoma (A549) cells via induction of reactive oxygen species‐mediated apoptotic and autophagic cell death

The kava chalcone flavokawain B exerts inhibitory activity and synergizes with BCL-2 inhibition in malignant B-cell lymphoma

2'-Hydroxychalcone Induces Autophagy and Apoptosis in Breast Cancer Cells via the Inhibition of the NF-κB Signaling Pathway: In Vitro and In Vivo Studies

A novel chalcone derivative has antitumor activity in melanoma by inducing DNA damage through the upregulation of ROS products

Biochanin A induces anticancer effects in SK-Mel-28 human malignant melanoma cells via induction of apoptosis, inhibition of cell invasion and modulation of NF-κB and MAPK signaling pathways

Flavokawain B Weakens Gastric Cancer Progression via the TGF-β1/SMAD4 Pathway and Attenuates M2 Macrophage Polarization

Design, Synthesis and Docking Studies of Flavokawain B Type Chalcones and Their Cytotoxic Effects on MCF-7 and MDA-MB-231 Cell Lines

Flavonoids Identified from Korean Scutellaria Baicalensis Induce Apoptosis by ROS Generation and Caspase Activation on Human Fibrosarcoma Cells.

Potential use of kiwifruit extract for treatment of melanoma

Oxyfadichalcone C Inhibits Melanoma A375 Cell Proliferation and Metastasis Via Suppressing PI3K/Akt and MAPK/ERK Pathways

β-acetoxyisovalerylalkannin suppresses proliferation and induces ROS-based mitochondria-mediated apoptosis in human melanoma cells

Harnessing the Power of Kiwifruit for Radiosensitization of Melanoma

Using Flavonoid Substitution Status to Predict Anticancer Effects in Human Melanoma Cancers: An In Vitro Study

Inhibition of glioma growth by flavokawain B is mediated through endoplasmic reticulum stress induced autophagy

Investigating the Anticancer Potential of Biochanin A in KB Oral Cancer Cells Through the NFκB Pathway

Quinalizarin induces cycle arrest and apoptosis via reactive oxygen species‐mediated signaling pathways in human melanoma A375 cells

Targeting STAT3 and NF-κB Signaling Pathways in Cancer Prevention and Treatment: The Role of Chalcones

Kushen Flavonoids Induce Apoptosis In Tumor Cells By Inhibition Of Nf-Kappa B Activation And Multiple Receptor Tyrosine Kinase Activities